Cargando…
Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies
INTRODUCTION: The combination of angiotensin-converting enzyme inhibitors and beta-blockers is recommended in a wide range of patients with hypertension, including those with stable coronary artery disease and/or elevated heart rate. This post hoc analysis of three observational studies provides eff...
Autores principales: | Abeel, Murielle, Gupta, Anil, Constance, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799572/ https://www.ncbi.nlm.nih.gov/pubmed/34755324 http://dx.doi.org/10.1007/s12325-021-01958-6 |
Ejemplares similares
-
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly
por: Sampalis, John S., et al.
Publicado: (2018) -
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study
por: Kobalava, Zhanna, et al.
Publicado: (2023) -
Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study
por: Boytsov, Sergey A., et al.
Publicado: (2021) -
Perindopril: the evidence of its therapeutic impact in hypertension
por: Thomson, Andrew, et al.
Publicado: (2007) -
Efficacy and Safety of Perindopril in Patients with Essential Hypertension
por: Hodzic, Enisa, et al.
Publicado: (2020)